2008-07-02 23:23:17 -
www.companiesandmarkets.com adds new report - Human Genome Sciences Inc. - SWOT Analysis www.companiesandmarkets.com/Summary-Company-Profile/Human-Genome ..
Human Genome Sciences Inc. Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Human Genome Sciences (HGS) is a global biopharmaceutical company that discovers and develops gene-based drugs to
treat and cure disease. The company has expertise in genomics and an exclusive focus on developing human protein and antibody drugs. The company’s therapeutic emphasis is on the areas of hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS. It is headquartered in Rockville, Maryland and employs about 900 people. The company recorded revenues of $26 million during the fiscal year ended December 2006, an increase of 36.8% over 2005. The operating loss of the company was $237 million during fiscal year 2006, an improvement of 5.9% over 2005. The net loss in fiscal year 2006 was $221 million, an improvement of 7.5% over 2005.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
